Medications for Leukemia Myeloid

18 results
Shantou Eelhoe Daily Chemical Technology Co., Ltd.
Usage: The section provided does not contain any specific information about the drug's indications and usages. Please provide additional details or context regarding the drug for an accurate summary.
PT. SUPER HOME PRODUCT INDONESIA
Usage: It appears that there is no specific drug information provided in your message. If you can provide the name or details about the drug, I can help summarize its indications and usages effectively.
Encube Ethicals Private Limited
Usage: The drug is indicated for the treatment of specific medical conditions, aiding in symptom relief and management. Always consult a healthcare provider for appropriate use tailored to individual health needs.
Tichy Anesthesia PA
Usage: It appears that the section provided does not contain any specific information regarding the indications and usages of the drug. Please provide additional details or text for a summary.
Yiwu Yucheng E Commerce Co Ltd
Usage: The drug is indicated for topical application twice daily, in the morning and night for men, and once for women. Following application, an active massage is recommended for 3-5 minutes until fully absorbed.
REMEDYREPACK INC.
Usage: Hydroxyurea capsules are indicated for the treatment of resistant chronic myeloid leukemia and locally advanced squamous cell carcinomas of the head and neck (excluding the lip) in combination with chemoradiation.
Teva Pharmaceuticals USA, Inc.
Usage: Hydroxyurea capsules are indicated for treating resistant chronic myeloid leukemia and for use in combination with chemoradiation for locally advanced squamous cell carcinomas of the head and neck (excluding the lip).

Iclusig (ponatinib hydrochloride)

(ponatinib hydrochloride)
Takeda Pharmaceuticals America, Inc.
Usage: ICLUSIG is indicated for adult patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL), both newly diagnosed (with chemotherapy) and as monotherapy for specific cases. It is also approved for Chronic Myeloid Leukemia (CML) in chronic, accelerated, or blast phases with prior resistance or intolerance to kinase inhibitors.
Boiron
Usage: To provide a summary of the indications and usages of the drug, I would need specific details or text regarding its intended uses, benefits, and any conditions it treats. Please provide that information for a concise summary.
Waylis Therapeutics LLC
Usage: MYLERAN (busulfan) is indicated for the palliative treatment of chronic myelogenous leukemia.